RIO-Diabetes: Obese Patients With Type 2 Diabetes

Sponsor
Sanofi (Industry)
Overall Status
Completed
CT.gov ID
NCT00029848
Collaborator
(none)
1,045
55
31
19
0.6

Study Details

Study Description

Brief Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Condition or Disease Intervention/Treatment Phase
  • Drug: Rimonabant (SR141716)
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
1045 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes
Study Start Date :
Oct 1, 2001
Actual Primary Completion Date :
May 1, 2004
Actual Study Completion Date :
May 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Change in body weight []

Secondary Outcome Measures

  1. Metabolic parameters []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
  • BMI must be greater than 27 and less than 40

  • Treated Type 2 Diabetes on single therapy treatment for at least 1 year

  • Stable weight (variation of less than 5 kg within 3 months prior to screening visit)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Innovative Clinical Trials Birmingham Alabama United States 35209
2 Lovelace Scientific Resources Phoenix Arizona United States 85016
3 Advanced Clinicla Therapeutics, LLC Tucson Arizona United States 85712
4 Southern California Prevention and Research Center Inc. (SPARC) Encino California United States 91436
5 Anderson Clinical Research San Bernardino California United States 92408
6 Diablo Clinical Research, Inc. Walnut Creek California United States 94598
7 North East Clinical Research Hamden Connecticut United States 06518
8 Clinical Research of South Florida Coral Gables Florida United States 33134
9 Jackson Downey, MD Jacksonville Florida United States 32205
10 Jacksonville Center for Clinical Research Jacksonville Florida United States 32205
11 Jacksonville Center for Clinical Research Jacksonville Florida United States 32216
12 DMI Helathcare Group Largo Florida United States 33773
13 Orlando Clinical Research Center Orlando Florida United States 32806
14 University Clinical Research Pembroke Pines Florida United States 33024
15 Comprehensive NeuroScience, Inc. Sarasota Florida United States 34232
16 Metabolic Research Institute West Palm Beach Florida United States 33401
17 CSRA Partners in Health, Inc. Augusta Georgia United States 30909
18 nTouch Research Marietta Georgia United States 30066
19 MediSphere Medical Research Center, LLC Evansville Indiana United States 47714
20 Physicians Research Group Indianapolis Indiana United States 46250
21 Kansas University Medical Center Kansas City Kansas United States 66160
22 Gulf States Clinical Trails, LLC Kenner Louisiana United States 70062
23 Medical Research Institute Slidell Louisiana United States 70458
24 Androscoggin Cardiology Associates Auburn Maine United States
25 Phase III Clinical Research Fall River Massachusetts United States 02720
26 JM Clinical Trials, Inc. Swansea Massachusetts United States 02777
27 Twin Cities Clinical Research Arden Hills Minnesota United States 55126
28 Lovelace Scientific Resources Las Vegas Nevada United States 89014
29 Endocrinology and Diabetes Consultants, PC Dover New Hampshire United States 03820
30 Radiant Reseach-Moorestown Moorestown New Jersey United States 08057
31 Lovelace Scientific Resources Albuquerque New Mexico United States 87108
32 Physician Clinical Research Service White Plains New York United States 10605
33 Center for Nutrition and Preventive Medicine Charlotte North Carolina United States 28207
34 Radiant Research Cincinnati Ohio United States 45236
35 MFP Research, Inc. Cincinnati Ohio United States 45242
36 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104
37 Radiant Research Portland Oregon United States 97201
38 Medical University of South Carolina, Division of Clinical Pharmacology Charleston South Carolina United States 29425
39 Costal Carolina Research Center Mt. Pleasant South Carolina United States 29464
40 TriCities Medical Reseach Bristol Tennessee United States 37620
41 Diabetes $ Glandular Disease Clinic, PA San Antonio Texas United States 78229-4810
42 Endocrine and Diabetes Ogden Utah United States 84403
43 National Clinical Research Richmond Virginia United States 23294
44 Salem Veterans Affairs Medical Center (151) Salem Virginia United States 24153
45 The Chase Wellness Center, Inc. Virginia Beach Virginia United States 23455
46 Sanofi-aventis Administrative Office Buenos Aires Argentina
47 Sanofi-aventis Administrative Office Diegem Belgium
48 Sanofi-aventis Administrative Office Laval Canada
49 Sanofi-aventis Administrative Office Praha Czech Republic
50 Sanofi-aventis Administrative Office Helsinki Finland
51 Sanofi-aventis Administrative Office Paris France
52 Sanofi-aventis Administrative Office Berlin Germany
53 Sanofi-aventis Administrative Office Gouda Netherlands
54 Sanofi-aventis Administrative office Warszawa Poland
55 Sanofi-aventis Administrative Office Guildford Surrey United Kingdom

Sponsors and Collaborators

  • Sanofi

Investigators

  • Study Director: ICD CSD, Sanofi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00029848
Other Study ID Numbers:
  • EFC4736
First Posted:
Jan 24, 2002
Last Update Posted:
Apr 20, 2009
Last Verified:
Apr 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2009